Sterilization effects on ultrathin film polymer coatings for silicon‐based implantable medical devices
Source abstract
Abstract
Abstract Novel biomaterials for medical device applications must be stable throughout all stages of preparation for surgery, including sterilization. There is a paucity of information on the effects of sterilization on sub‐10 nm‐thick polymeric surface coatings suitable for silicon‐based bioartificial organs. This study explores the effect of five standard sterilization methods on three surface coatings applied to silicon: polyethylene glycol (PEG), poly(sulfobetaine methacrylate) (pSBMA), and poly (2‐methacryloyloxyethyl phosphorylcholine) (pMPC). Autoclave, dry heat, hydrogen peroxide (H2O2) plasma, ethylene oxide gas (EtO), and electron beam (E‐beam) treated coatings were analyzed to determine possible polymer degradation with sterilization. Poststerilization, there were significant alterations in contact angle, maximum change resulting from H2O2 (Δ − 14°), autoclave (Δ + 15°), and dry heat (Δ + 23°) treatments for PEG, pSBMA, and pMPC, respectively. Less than 5% coating thickness change was found with autoclave and EtO on PEG‐silicon, E‐beam on pSBMA‐silicon and EtO treatment on pMPC‐silicon. H2O2 treatment resulted in at least 30% decrease in thickness for all coatings. Enzyme‐linked immunosorbent assays showed significant protein adsorption increase for pMPC‐silicon following all sterilization methods. E‐beam on PEG‐silicon and dry‐heat treatment on pSBMA‐silicon exhibited maximum protein adsorption in each coating subset. Overall, the data suggest autoclave and EtO treatments are well‐suited for PEG‐silicon, while E‐beam is best suited for pSBMA‐silicon. pMPC‐silicon was least impacted by EtO treatment. H2O2 treatment had a negative effect on all three coatings. These results can be used to determine which surface modifications and sterilization processes to utilize for devices in vivo. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2327–2336, 2018.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Bone Tissue Engineering Materials · Nanofabrication and Lithography Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering & Therapeutic Sciences University of California ‐ San Francisco (UCSF) San Francisco California
Department of Surgery UCSF San Francisco California
Division of Nephrology UCSF San Francisco California
Division of Nephrology and Hypertension Vanderbilt University Medical Center Nashville Tennessee
Funding
National Institutes of Health
References (44)
Show source-provided references
1. 10.1016/j.sse.2006.03.02310.1016/j.sse.2006.03.023 ↗
2. 10.1016/S1359-0286(02)00032-310.1016/S1359-0286(02)00032-3 ↗
3. Desai T · 2007 · 263
4. 10.1016/S1389-0344(00)00063-010.1016/S1389-0344(00)00063-0 ↗
5. 10.1089/dia.2005.7.15110.1089/dia.2005.7.151 ↗
6. 10.1016/S0376-7388(99)00062-910.1016/S0376-7388(99)00062-9 ↗
7. 10.1038/srep2367910.1038/srep23679 ↗
8. 10.1039/C7LC00096K10.1039/C7LC00096K ↗
9. 10.1109/SENSOR.2009.528560310.1109/SENSOR.2009.5285603 ↗
10. 10.1038/nature0553210.1038/nature05532 ↗
11. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008
12. 10.1111/j.1525-139X.2009.00662.x10.1111/j.1525-139X.2009.00662.x ↗
13. 10.1371/journal.pone.015952610.1371/journal.pone.0159526 ↗
14. 10.1007/s10439-011-0256-y10.1007/s10439-011-0256-y ↗
15. 10.1016/S0142-9612(03)00113-310.1016/S0142-9612(03)00113-3 ↗
16. 10.1016/j.memsci.2008.09.03910.1016/j.memsci.2008.09.039 ↗
17. Silicon induces minimal thromboinflammatory response during 28‐day intravascular implant testing10.1097/MAT.0b013e3181d98cf8 ↗
18. 10.1016/j.bios.2003.10.00710.1016/j.bios.2003.10.007 ↗
19. 10.1016/S0142-9612(98)00026-X10.1016/S0142-9612(98)00026-X ↗
20. 10.1016/j.colsurfb.2010.03.02710.1016/j.colsurfb.2010.03.027 ↗
21. 10.1016/S0925-4005(01)00925-X10.1016/S0925-4005(01)00925-X ↗
22. 10.1002/adma.20030583010.1002/adma.200305830 ↗
23. 10.1016/j.memsci.2013.02.01910.1016/j.memsci.2013.02.019 ↗
24. 10.1016/j.biomaterials.2003.09.02010.1016/j.biomaterials.2003.09.020 ↗
25. 10.1016/j.bios.2004.01.03410.1016/j.bios.2004.01.034 ↗
26. 10.1016/j.biomaterials.2008.07.03910.1016/j.biomaterials.2008.07.039 ↗
27. 10.1021/la062175d10.1021/la062175d ↗
28. 10.1021/la052851w10.1021/la052851w ↗
29. 10.1163/156856208X38644410.1163/156856208X386444 ↗
30. 10.1126/scitranslmed.300412010.1126/scitranslmed.3004120 ↗
31. 10.1016/S0142-9612(02)00007-810.1016/S0142-9612(02)00007-8 ↗
32. 10.1016/j.actbio.2008.06.01310.1016/j.actbio.2008.06.013 ↗
33. 10.1002/jbm.b.3087410.1002/jbm.b.30874 ↗
34. 10.1002/jbm.a.3181110.1002/jbm.a.31811 ↗
35. 10.1163/092050609X1257849898299810.1163/092050609X12578498982998 ↗
36. Centers for Disease Control and Prevention‐Guidelines for Disinfection and Sterilization in Healthcare Facilities (Other Sterilization Methods);2016.https://www.cdc.gov/infectioncontrol/guidelines/disinfection/sterilization/other-methods.html. Accessed May 6 2017.
37. 10.1016/j.actbio.2009.12.03510.1016/j.actbio.2009.12.035 ↗
38. Krzysztof P · 2005
39. 10.1016/S0032-3861(97)88175-X10.1016/S0032-3861(97)88175-X ↗
40. 10.4236/jbnb.2011.2404510.4236/jbnb.2011.24045 ↗
41. 10.1016/0142-9612(80)90037-X10.1016/0142-9612(80)90037-X ↗
42. Silindir M · 2009 · 43
43. 10.1023/A:100993850793510.1023/A:1009938507935 ↗
44. 10.1115/1.400253210.1115/1.4002532 ↗